Lv1
20 积分 2024-05-05 加入
Clinical experience with PSMA-Actinium-225 (Ac-225) radioligand therapy (RLT) in end-stage metastatic castration-resistant prostate cancer (mCRPC) patients
5小时前
求助中
Efficacy and Safety of Actinium-225 Prostate-Specific Membrane Antigen Radioligand Therapy in Metastatic Prostate Cancer: A Systematic Review and Metanalysis
5小时前
已完结
Actinium-225 Targeted Agents: Where Are We Now?
2天前
已完结
Ignorance is Bliss? A Case of Incidental Discovery of ATM Mutation in Prostate Cancer
4天前
求助中
Simultaneous Prostate and Bladder Cancer with Collision Lymph Node Metastasis: A Case Report and Literature Review
4天前
已完结
Liver Enzyme Elevation After 177Lu-PSMA Radioligand Therapy for Metastasized Castration-Resistant Prostate Cancer
6天前
已完结
Sowing the Seeds: A Case of Oligometastatic Anal Cancer 12 Years After Prostate Brachytherapy
6天前
已完结
[177Lu]Lu-Prostate-Specific Membrane Antigen-617 in a Patient with Metastatic Castration-Resistant Prostate Cancer and Status After Bilateral Nephrectomy
6天前
已关闭
Peritoneal Metastases From Prostate Carcinoma Treated With 177Lu-PSMA-I&T
7天前
已完结
177Lu-DOTA-IBA Therapy in Prostate Cancer With Bone Metastases
7天前
已完结
皖公网安备34019202002308
